The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

1:42 B.C. Conservatives release leaked Ministry of Health presentation on safe supply A “significant portion” of opioids prescribed by doctors and pharmacists in British Columbia are being ...

The legislation permanently reclassifies fentanyl as a Schedule I drug, meaning it has no accepted medical use and a high ...

The bill would permanently classify the opioid as Schedule 1 under the Controlled Substances Act, joining drugs such as heroin and LSD.

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing ...

Journavx’s value proposition as an opioid alternative, however, should not b Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges ...

The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, for the treatment of moderate to severe acute pain in adults, the ...

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while also finding an overall positive trend, with a drop in opioid prescription ...

The leaders of Mexico and Canada each said they had struck agreements to pause tariffs for 30 days, but levies on products ...